Menu

1 / 2

Tiziana Life Sciences Ltd (TLSA) Discusses Positive Phase 2a INFORM-MS Results for Intranasal Foralumab in Nonactive Secondary Progressive Multiple Sclerosis - Slideshow

All Articles on Seeking Alpha·2 days ago
#ycLsQ2iV
Reading 0:00
15s threshold

The following slide deck was published by Tiziana Life Sciences Ltd in conjunction with this event.

Tiziana Life Sciences Ltd (TLSA) Discusses Positive Phase 2a INFORM-MS Results for Intranasal Foralumab in Nonactive Secondary Progressive Multiple Sclerosis - Slideshow

SA Transcripts

163.04K Followers

This article was written by

163.04K Followers

Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts Team